A50G (p.Ala50Gly) variant of MYPN (Myopalladin)
A50G (p.Ala50Gly) in MYPN (Myopalladin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
A50G (p.Ala50Gly) variant details
- p.Ala50Gly
- NCI-TCGA Cosmic COSV6273
- cosmic curated COSV62731
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available